Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bertrand

Showing results (451-460 of 462) with videos related to

Pageof 47
Sort By:
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
The Canadian Journal of Cardiology|December 25, 2013
Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trialJosep Rodés-Cabau, Olivier F Bertrand, Eric Larose, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.
JAMA|March 17, 2011
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trialMatthew J Price, Peter B Berger, Paul S Teirstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL TrialMarc-André d'Entremont, Ashraf Alazzoni, Vladimir Dzavik, et al.
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
The American Journal of Cardiology|October 26, 2019
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)Chun Chin Chang, Ernest Spitzer, Ply Chichareon, et al.
American Heart Journal|March 5, 2013
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research ConsortiumConnie N Hess, Sunil V Rao, David F Kong, et al.
Lancet (London, England)|October 18, 2015
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trialSanjit S Jolly, John A Cairns, Salim Yusuf, et al.
Pageof 47

Showing results (451-460 of 462) with videos related to

Sort By:
Pageof 47
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
The Canadian Journal of Cardiology|December 25, 2013
Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trialJosep Rodés-Cabau, Olivier F Bertrand, Eric Larose, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.
JAMA|March 17, 2011
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trialMatthew J Price, Peter B Berger, Paul S Teirstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL TrialMarc-André d'Entremont, Ashraf Alazzoni, Vladimir Dzavik, et al.
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
The American Journal of Cardiology|October 26, 2019
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)Chun Chin Chang, Ernest Spitzer, Ply Chichareon, et al.
American Heart Journal|March 5, 2013
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research ConsortiumConnie N Hess, Sunil V Rao, David F Kong, et al.
Lancet (London, England)|October 18, 2015
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trialSanjit S Jolly, John A Cairns, Salim Yusuf, et al.
Pageof 47